Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:ArikayceIndication |
treatment of Mycobacterium avium complex lung disease
|
| gptkbp:CEO |
gptkb:William_H._Lewis
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
orphan drugs
rare diseases |
| gptkbp:foundedBy |
gptkb:Geoffrey_Allan
|
| gptkbp:foundedIn |
1999
|
| gptkbp:headquartersLocation |
gptkb:Bridgewater,_New_Jersey,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Insmed
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
Arikayce
|
| gptkbp:numberOfEmployees |
over 600
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:researchInterest |
pulmonary diseases
rare lung diseases |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
INSM
|
| gptkbp:tradedOn |
NASDAQ:INSM
|
| gptkbp:website |
https://www.insmed.com/
|
| gptkbp:bfsParent |
gptkb:Deerfield_Management
|
| gptkbp:bfsLayer |
8
|